Contents
pdf Download PDF
pdf Download XML
17 Views
0 Downloads
Share this article
Research Article | Volume: 28 Issue 1 (Jan-Dec, 2023) | Pages 1 - 3
Drug-Eluting Stents: Long-Term Outcomes and Innovations in Stent Design
1
Division of Interventional Cardiology, Cleveland Clinic
Under a Creative Commons license
Open Access
Published
Sept. 19, 2023
Abstract

Drug-eluting stents (DES) have revolutionized the treatment of coronary artery disease (CAD), significantly reducing the incidence of restenosis compared to bare-metal stents (BMS). Advances in stent technology, including improvements in polymer coatings, drug-elution profiles, and stent platforms, have enhanced long-term outcomes. This review focuses on the long-term efficacy and safety of DES, highlighting innovations in stent design and materials that aim to further reduce the risks of late restenosis, stent thrombosis, and the need for repeat revascularization. Challenges such as late stent thrombosis, dual antiplatelet therapy (DAPT) duration, and the emergence of bioresorbable stents are also discussed.

Keywords
Recommended Articles
Research Article
Dynamic Cardiac CT: A Game Changer in Coronary Plaque Assessment
...
Published: 31/12/2022
Research Article
Percutaneous Mitral Valve Repair: Successes and Challenges
...
Published: 30/12/2023
Research Article
Strain Imaging and its Clinical Relevance in Left Ventricular Dysfunction
...
Published: 31/12/2022
Research Article
Automated Detection of Cardiac Arrhythmias Using Wearable Technology
...
Published: 31/12/2022
Chat on WhatsApp
© Copyright Dialogues in Cardiovascular Medicine